Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor

Identifieur interne : 001752 ( Pmc/Curation ); précédent : 001751; suivant : 001753

Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor

Auteurs : Tatiana V. Petrova ; Taija M Kinen ; Tomi P. M Kel ; Janna Saarela ; Ismo Virtanen ; Robert E. Ferrell ; David N. Finegold ; Dontscho Kerjaschki ; Seppo Yl Herttuala ; Kari Alitalo

Source :

RBID : PMC:125413

Abstract

Lymphatic vessels are essential for fluid homeostasis, immune surveillance and fat adsorption, and also serve as a major route for tumor metastasis in many types of cancer. We found that isolated human primary lymphatic and blood vascular endothelial cells (LECs and BECs, respectively) show interesting differences in gene expression relevant for their distinct functions in vivo. Although these phenotypes are stable in vitro and in vivo, overexpression of the homeobox transcription factor Prox-1 in the BECs was capable of inducing LEC-specific gene transcription in the BECs, and, surprisingly, Prox-1 suppressed the expression of ∼40% of the BEC-specific genes. Prox-1 did not have global effects on the expression of LEC-specific genes in other cell types, except that it up-regulated cyclin E1 and E2 mRNAs and activated the cyclin e promoter in various cell types. These data suggest that Prox-1 acts as a cell proliferation inducer and a fate determination factor for the LECs. Furthermore, the data provide insights into the phenotypic diversity of endothelial cells and into the possibility of transcriptional reprogramming of differentiated endothelial cells.


Url:
DOI: 10.1093/emboj/cdf470
PubMed: 12198161
PubMed Central: 125413

Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:125413

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor</title>
<author>
<name sortKey="Petrova, Tatiana V" sort="Petrova, Tatiana V" uniqKey="Petrova T" first="Tatiana V." last="Petrova">Tatiana V. Petrova</name>
</author>
<author>
<name sortKey="M Kinen, Taija" sort="M Kinen, Taija" uniqKey="M Kinen T" first="Taija" last="M Kinen">Taija M Kinen</name>
</author>
<author>
<name sortKey="M Kel, Tomi P" sort="M Kel, Tomi P" uniqKey="M Kel T" first="Tomi P." last="M Kel">Tomi P. M Kel</name>
<affiliation>
<nlm:aff id="N0x9921fd8.0x98aa4f8"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Saarela, Janna" sort="Saarela, Janna" uniqKey="Saarela J" first="Janna" last="Saarela">Janna Saarela</name>
<affiliation>
<nlm:aff id="N0x9921fd8.0x98aa4f8"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Virtanen, Ismo" sort="Virtanen, Ismo" uniqKey="Virtanen I" first="Ismo" last="Virtanen">Ismo Virtanen</name>
<affiliation>
<nlm:aff id="N0x9921fd8.0x98aa4f8"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Ferrell, Robert E" sort="Ferrell, Robert E" uniqKey="Ferrell R" first="Robert E." last="Ferrell">Robert E. Ferrell</name>
<affiliation>
<nlm:aff id="N0x9921fd8.0x98aa4f8"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Finegold, David N" sort="Finegold, David N" uniqKey="Finegold D" first="David N." last="Finegold">David N. Finegold</name>
<affiliation>
<nlm:aff id="N0x9921fd8.0x98aa4f8"></nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="N0x9921fd8.0x98aa4f8"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Kerjaschki, Dontscho" sort="Kerjaschki, Dontscho" uniqKey="Kerjaschki D" first="Dontscho" last="Kerjaschki">Dontscho Kerjaschki</name>
<affiliation>
<nlm:aff id="N0x9921fd8.0x98aa4f8"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Yl Herttuala, Seppo" sort="Yl Herttuala, Seppo" uniqKey="Yl Herttuala S" first="Seppo" last="Yl Herttuala">Seppo Yl Herttuala</name>
<affiliation>
<nlm:aff id="N0x9921fd8.0x98aa4f8"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Alitalo, Kari" sort="Alitalo, Kari" uniqKey="Alitalo K" first="Kari" last="Alitalo">Kari Alitalo</name>
<affiliation>
<nlm:aff id="N0x9921fd8.0x98aa4f8"></nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">12198161</idno>
<idno type="pmc">125413</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC125413</idno>
<idno type="RBID">PMC:125413</idno>
<idno type="doi">10.1093/emboj/cdf470</idno>
<date when="2002">2002</date>
<idno type="wicri:Area/Pmc/Corpus">001753</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001753</idno>
<idno type="wicri:Area/Pmc/Curation">001752</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001752</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor</title>
<author>
<name sortKey="Petrova, Tatiana V" sort="Petrova, Tatiana V" uniqKey="Petrova T" first="Tatiana V." last="Petrova">Tatiana V. Petrova</name>
</author>
<author>
<name sortKey="M Kinen, Taija" sort="M Kinen, Taija" uniqKey="M Kinen T" first="Taija" last="M Kinen">Taija M Kinen</name>
</author>
<author>
<name sortKey="M Kel, Tomi P" sort="M Kel, Tomi P" uniqKey="M Kel T" first="Tomi P." last="M Kel">Tomi P. M Kel</name>
<affiliation>
<nlm:aff id="N0x9921fd8.0x98aa4f8"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Saarela, Janna" sort="Saarela, Janna" uniqKey="Saarela J" first="Janna" last="Saarela">Janna Saarela</name>
<affiliation>
<nlm:aff id="N0x9921fd8.0x98aa4f8"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Virtanen, Ismo" sort="Virtanen, Ismo" uniqKey="Virtanen I" first="Ismo" last="Virtanen">Ismo Virtanen</name>
<affiliation>
<nlm:aff id="N0x9921fd8.0x98aa4f8"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Ferrell, Robert E" sort="Ferrell, Robert E" uniqKey="Ferrell R" first="Robert E." last="Ferrell">Robert E. Ferrell</name>
<affiliation>
<nlm:aff id="N0x9921fd8.0x98aa4f8"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Finegold, David N" sort="Finegold, David N" uniqKey="Finegold D" first="David N." last="Finegold">David N. Finegold</name>
<affiliation>
<nlm:aff id="N0x9921fd8.0x98aa4f8"></nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="N0x9921fd8.0x98aa4f8"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Kerjaschki, Dontscho" sort="Kerjaschki, Dontscho" uniqKey="Kerjaschki D" first="Dontscho" last="Kerjaschki">Dontscho Kerjaschki</name>
<affiliation>
<nlm:aff id="N0x9921fd8.0x98aa4f8"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Yl Herttuala, Seppo" sort="Yl Herttuala, Seppo" uniqKey="Yl Herttuala S" first="Seppo" last="Yl Herttuala">Seppo Yl Herttuala</name>
<affiliation>
<nlm:aff id="N0x9921fd8.0x98aa4f8"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Alitalo, Kari" sort="Alitalo, Kari" uniqKey="Alitalo K" first="Kari" last="Alitalo">Kari Alitalo</name>
<affiliation>
<nlm:aff id="N0x9921fd8.0x98aa4f8"></nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">The EMBO Journal</title>
<idno type="ISSN">0261-4189</idno>
<idno type="eISSN">1460-2075</idno>
<imprint>
<date when="2002">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>Lymphatic vessels are essential for fluid homeostasis, immune surveillance and fat adsorption, and also serve as a major route for tumor metastasis in many types of cancer. We found that isolated human primary lymphatic and blood vascular endothelial cells (LECs and BECs, respectively) show interesting differences in gene expression relevant for their distinct functions
<italic>in vivo</italic>
. Although these phenotypes are stable
<italic>in vitro</italic>
and
<italic>in vivo</italic>
, overexpression of the homeobox transcription factor Prox-1 in the BECs was capable of inducing LEC-specific gene transcription in the BECs, and, surprisingly, Prox-1 suppressed the expression of ∼40% of the BEC-specific genes. Prox-1 did not have global effects on the expression of LEC-specific genes in other cell types, except that it up-regulated cyclin E1 and E2 mRNAs and activated the
<italic>cyclin e</italic>
promoter in various cell types. These data suggest that Prox-1 acts as a cell proliferation inducer and a fate determination factor for the LECs. Furthermore, the data provide insights into the phenotypic diversity of endothelial cells and into the possibility of transcriptional reprogramming of differentiated endothelial cells.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article">
<pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">EMBO J</journal-id>
<journal-title>The EMBO Journal</journal-title>
<issn pub-type="ppub">0261-4189</issn>
<issn pub-type="epub">1460-2075</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
<publisher-loc>Oxford, UK</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">12198161</article-id>
<article-id pub-id-type="pmc">125413</article-id>
<article-id pub-id-type="publisher-id">cdf470</article-id>
<article-id pub-id-type="doi">10.1093/emboj/cdf470</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Petrova</surname>
<given-names>Tatiana V.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mäkinen</surname>
<given-names>Taija</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mäkelä</surname>
<given-names>Tomi P.</given-names>
</name>
<xref ref-type="aff" rid="N0x9921fd8.0x98aa4f8">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Saarela</surname>
<given-names>Janna</given-names>
</name>
<xref ref-type="aff" rid="N0x9921fd8.0x98aa4f8">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Virtanen</surname>
<given-names>Ismo</given-names>
</name>
<xref ref-type="aff" rid="N0x9921fd8.0x98aa4f8">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ferrell</surname>
<given-names>Robert E.</given-names>
</name>
<xref ref-type="aff" rid="N0x9921fd8.0x98aa4f8">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Finegold</surname>
<given-names>David N.</given-names>
</name>
<xref ref-type="aff" rid="N0x9921fd8.0x98aa4f8">4</xref>
<xref ref-type="aff" rid="N0x9921fd8.0x98aa4f8">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kerjaschki</surname>
<given-names>Dontscho</given-names>
</name>
<xref ref-type="aff" rid="N0x9921fd8.0x98aa4f8">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ylä-Herttuala</surname>
<given-names>Seppo</given-names>
</name>
<xref ref-type="aff" rid="N0x9921fd8.0x98aa4f8">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alitalo</surname>
<given-names>Kari</given-names>
</name>
<xref ref-type="aff" rid="N0x9921fd8.0x98aa4f8">8</xref>
</contrib>
</contrib-group>
<aff id="N0x9921fd8.0x98aa4f8">Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research, Haartman Institute and Helsinki University Central Hospital,
<label>1</label>
Cell Cycle Laboratory,
<label>2</label>
National Public Health Institute and
<label>3</label>
Department of Anatomy, Biomedicum Helsinki, University of Helsinki, 00014 Helsinki,
<label>4</label>
Department of Human Genetics and
<label>5</label>
Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USA,
<label>6</label>
Department of Pathology, University of Vienna Medical School, 1090 Vienna, Austria and
<label>7</label>
Department of Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, 70211 Kuopio, Finland
<label>8</label>
Corresponding author e-mail: Kari.Alitalo@Helsinki.FI T.V.Petrova and T.Mäkinen contributed equally to this work</aff>
<pub-date pub-type="ppub">
<day>2</day>
<month>9</month>
<year>2002</year>
</pub-date>
<volume>21</volume>
<issue>17</issue>
<fpage>4593</fpage>
<lpage>4599</lpage>
<ext-link ext-link-type="uri" xlink:href="http://www.emboj.oupjournals.org/content/vol21/issue17/"></ext-link>
<history>
<date date-type="received">
<day>17</day>
<month>6</month>
<year>2002</year>
</date>
<date date-type="rev-recd">
<day>17</day>
<month>7</month>
<year>2002</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>7</month>
<year>2002</year>
</date>
</history>
<copyright-statement>Copyright © 2002 European Molecular Biology Organization</copyright-statement>
<copyright-year>2002</copyright-year>
<abstract>
<p>Lymphatic vessels are essential for fluid homeostasis, immune surveillance and fat adsorption, and also serve as a major route for tumor metastasis in many types of cancer. We found that isolated human primary lymphatic and blood vascular endothelial cells (LECs and BECs, respectively) show interesting differences in gene expression relevant for their distinct functions
<italic>in vivo</italic>
. Although these phenotypes are stable
<italic>in vitro</italic>
and
<italic>in vivo</italic>
, overexpression of the homeobox transcription factor Prox-1 in the BECs was capable of inducing LEC-specific gene transcription in the BECs, and, surprisingly, Prox-1 suppressed the expression of ∼40% of the BEC-specific genes. Prox-1 did not have global effects on the expression of LEC-specific genes in other cell types, except that it up-regulated cyclin E1 and E2 mRNAs and activated the
<italic>cyclin e</italic>
promoter in various cell types. These data suggest that Prox-1 acts as a cell proliferation inducer and a fate determination factor for the LECs. Furthermore, the data provide insights into the phenotypic diversity of endothelial cells and into the possibility of transcriptional reprogramming of differentiated endothelial cells.</p>
</abstract>
<kwd-group>
<kwd>gene profiling/lymphatic endothelium/transcription factor Prox-1</kwd>
</kwd-group>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001752 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 001752 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Pmc
   |étape=   Curation
   |type=    RBID
   |clé=     PMC:125413
   |texte=   Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i   -Sk "pubmed:12198161" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024